Neurochemical and Behavioral Effects of Cannabinoid CB1 Agonist in Male Mice

被引：0
|
作者：
Smith, Evan [1 ]
Alkhelb, Dalal [1 ]
Iliopoulos-Tsoutsouvas, Christos [1 ]
Nikas, Spyros [1 ]
Makriyannis, Alexandros [1 ]
Desai, Rajeev [2 ]
机构：
[1] Northeastern Univ, Boston, MA USA
[2] Harvard Med Sch, McLean Hosp, Boston, MA USA
来源：
DRUG AND ALCOHOL DEPENDENCE | 2025年 / 267卷
关键词：
D O I：
10.1016/j.drugalcdep.2024.112278
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
    Landsman, RS
    Burkey, TH
    Consroe, P
    Roeske, WR
    Yamamura, HI
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (01) : R1 - R2
  • [32] Crystal structures of agonist-bound human cannabinoid receptor CB1
    Hua, Tian
    Vemuri, Kiran
    Nikas, Spyros P.
    Laprairie, Robert B.
    Wu, Yiran
    Qu, Lu
    Pu, Mengchen
    Korde, Anisha
    Jiang, Shan
    Ho, Jo-Hao
    Han, Gye Won
    Ding, Kang
    Li, Xuanxuan
    Liu, Haiguang
    Hanson, Michael A.
    Zhao, Suwen
    Bohn, Laura M.
    Makriyannis, Alexandros
    Stevens, Raymond C.
    Liu, Zhi-Jie
    NATURE, 2017, 547 (7664) : 468 - +
  • [33] Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats
    Ding, Yuanyuan
    Qiu, Yanyan
    Jing, Li
    Thorn, David A.
    Zhang, Yanan
    Li, Jun-Xu
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2014, 2 (06):
  • [34] Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors
    Leggett, JD
    Aspley, S
    Beckett, SRG
    D'Antona, AM
    Kendall, DA
    Kendall, DA
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (02) : 253 - 262
  • [35] AM630 is an inverse agonist at the human cannabinoid CB1 receptor
    Landsman, RS
    Makriyannis, A
    Deng, HF
    Consroe, P
    Roeske, WR
    Yamamura, HI
    LIFE SCIENCES, 1998, 62 (09) : PL109 - PL113
  • [36] Crystal structures of agonist-bound human cannabinoid receptor CB1
    Tian Hua
    Kiran Vemuri
    Spyros P. Nikas
    Robert B. Laprairie
    Yiran Wu
    Lu Qu
    Mengchen Pu
    Anisha Korde
    Shan Jiang
    Jo-Hao Ho
    Gye Won Han
    Kang Ding
    Xuanxuan Li
    Haiguang Liu
    Michael A. Hanson
    Suwen Zhao
    Laura M. Bohn
    Alexandros Makriyannis
    Raymond C. Stevens
    Zhi-Jie Liu
    Nature, 2017, 547 : 468 - 471
  • [37] Analysis of Tolerance and Behavioral/Physical Dependence during Chronic CB1 Agonist Treatment: Effects of CB1 Agonists, Antagonists, and Noncannabinoid Drugs
    Desai, Rajeev I.
    Thakur, Ganesh A.
    Vemuri, V. Kiran
    Bajaj, Shama
    Makriyannis, Alexandros
    Bergman, Jack
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 344 (02): : 319 - 328
  • [38] Basolateral amygdala cannabinoid CB1 receptors mediate the antinociceptive activity of harmaline in adolescent male mice
    Alijanpour, Sakineh
    Ghasemzadeh, Zahra
    Ebrahimi-Ghiri, Mohaddeseh
    Zarrindast, Mohammad-Reza
    PHYSIOLOGY & BEHAVIOR, 2022, 254
  • [39] The CB1 cannabinoid receptor in the brain
    Howlett, AC
    NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 405 - 416
  • [40] Cannabinoid CB1 Receptor Antagonists
    Thomas, Brian F.
    DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
12345